Wacker Biotech B.V.: Catching up with renovation
While the parenterals industry has continuously expanded in recent years. Buyers of contract manufacturing have more choice and expect advanced services using the latest technologies, Wacker Biotech announces modernisation of its Dutch plant. It appears overdue since the takeover of the Amsterdam facility from SynCo Bio Partners in April 2018. Analysis by B2Bioworld.Reading time: 2 minRead more ...
Other articles recommended
B2Bioworld offers you background information